FORTARO

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

지금 구매하세요

공공 평가 보고서 공공 평가 보고서 (PAR)
11-01-2021

유효 성분:

calcifediol monohydrate, Quantity: 0.01 mg

제공처:

DSM Nutritional Products Australia Pty Ltd

약제 형태:

Tablet, uncoated

구성:

Excipient Ingredients: magnesium stearate; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; silicon dioxide; croscarmellose sodium; crospovidone; starch sodium octenyl succinate; sodium ascorbate; dl-alpha-tocopherol; sucrose; medium chain triglycerides

관리 경로:

Oral

치료 징후:

Maintain/support general health and wellbeing ; Maintain/support healthy teeth ; Maintain/support bone health ; Aids/assists healthy bone development/growth/building ; Help maintain/support bone mineralisation ; Maintain/support heart health ; Maintain/support immune system health ; Maintain/support healthy immune system function ; Maintain/support muscle health ; Maintain/support muscle function ; Maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; Maintain/support (state vitamin/mineral/nutrient) levels in the body ; Helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; Maintain/support neuromuscular function ; Maintain/support nervous system health

제품 요약:

Visual Identification: ;

승인 상태:

Listed

승인 날짜:

2020-11-27

문서 기록보기